Who Just Raised

NewcelX Ltd.

Kloten, Switzerland ยท Biotechnology

NewcelX Ltd. is a biotechnology company based in Kloten, Switzerland. In a Form D filed with the SEC on August 24, 2026, it reported raising $2,940,234 from 5 investors as part of an offering of up to $2,940,234. The first sale in the offering took place on July 3, 2026.

Amount raised
$2,940,234
Offering size
$2,940,234
Investors so far
5
First sale
July 3, 2026
Securities offered
Equity, Options or warrants, Securities issuable on exercise or conversion, Other
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Kloten, Switzerland
Incorporated
Switzerland
Entity type
Other

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $2,940,234 $2,940,234 5 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises

Company Location Sector Raised Target Filed
Curadel Surgical Innovations, Inc. Bonita Springs, FL Health Care $49.8M $57.5M
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
iPill Inc. Rowland Heights, CA Health Care $1.3M $1.5M
Dvant Pharma, Inc. Superior Township, MI Health Care $1.2M $3.1M
FibroBiologics, Inc. Houston, TX Health Care $1.2M $1.2M
Vimy Pharmaceuticals Inc. Toronto, Ontario, Canada Health Care $1M $1M